Announcement on Interest Payment for "Aurisco Convertible Bonds" in 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Interest Payment for "Aurisco Convertible Bonds" in 2025
Filed with SSE ·
6ix hasn’t read this filing yet.
Aurisco Pharmaceutical Co. Ltd. on 6ix
Story so far
Earlier from Aurisco Pharmaceutical
- Announcement on 2025 Tracking Credit Rating Results of "Aurisco Convertible Bonds"
- Announcement on Passing On-site Inspection by FDA
- Announcement on Adjusting Upper Limit of Shares Repurchase Price after Implementing Dividend Distribution for 2024
- Announcement on Adjusting the Total Cash Dividends for Profit Distribution in 2024
- Indicative Announcement on Suspending Conversion of "Aurisco Convertible Bonds" during Implementation of Dividend Distribution for 2024
Later from Aurisco Pharmaceutical
- Announcement on Redemption upon Maturity of Partial Idle Raised Funds Used for Cash Management
- Announcement on Shareholding Reduction Plan for Partial Senior Executives
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Announcement on Redemption of Partial Idle Raised Funds Used for Cash Management upon Expiration and Continuously Conducting Cash Management
- Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
Follow Aurisco Pharmaceutical into a list and get an email when it puts out news.
Follow Aurisco Pharmaceutical